Systematic Reviews Related to TTP
- Soares Ferreira Junior A. Patient-Reported Outcome Measures in Patients with Thrombotic Thrombocytopenic Purpura: A Systematic Review of the Literature. J Clin Med. 2023 Aug 7;12(15):5155. PMID: 37568558
- Schofield J. Drug-induced thrombotic thrombocytopenic purpura: A systematic review and review of European and North American pharmacovigilance data. Br J Haematol. 2023 May;201(4):766-773. PMID: 36477772
- Du P et al. A Systematic Review of the Epidemiology and Disease Burden of Congenital and Immune-Mediated Thrombotic Thrombocytopenic Purpura. J Blood Med. 2024 Aug 14;15:363-386. PMID: 39161536
- Peng JY et al. Efficacy and relative safety of caplacizumab in immune-mediated thrombotic thrombocytopenic purpura: a systematic review and meta-analysis. Blood Coagul Fibrinolysis. 2024 Jul 1;35(5):271-278. PMID: 38874905
- Neupane N et al. Does Caplacizumab for the management of thrombotic thrombocytopenic purpura increase the risk of relapse, exacerbation, and bleeding? An updated systematic review and meta-analysis based on revised criteria by the International Working Group for thrombotic thrombocytopenic purpura. EJHaem. 2023 Dec 18;5(1):178-190. PMID: 38406548
- Khan S et al. Drug-induced thrombotic microangiopathy and thrombotic thrombocytopenic purpura: A systematic review, 2018-2023. Am J Hematol. 2023 Dec;98(12):E373-E375. PMID: 37753669